Cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic/pharmacodynamic considerations

Daniel E. Hilleman, C. K. Nair

Research output: Contribution to journalReview article

Abstract

Advancing age is associated with important changes in the absorption, distribution, metabolism, and elimination of cardiovascular drugs. In this issue, Drs. Hilleman and Nair discuss cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic and pharmacodynamic considerations. Following this, Dr. Rich reviews three recent articles on the use of angiotensin-converting-enzyme inhibitors in patients at risk for developing congestive heart failure, and another article on the exclusion of elderly subjects and women from clinical trials of pharmacologic interventions in acute myocardial infarction. Also included in this issue are a comprehensive annotated bibliography of the recent literature relevant to cardiovascular disease in the elderly, a report from the Council on Geriatric Cardiology summarizing recent research activities of the Council, and a calendar of upcoming meetings and events.

Original languageEnglish
Pages (from-to)15-20+25
JournalCardiovascular Reviews and Reports
Volume13
Issue number11
StatePublished - 1992

Fingerprint

Cardiovascular Agents
Pharmacokinetics
Drug Therapy
Bibliography
Cardiology
Angiotensin-Converting Enzyme Inhibitors
Geriatrics
Cardiovascular Diseases
Heart Failure
Myocardial Infarction
Clinical Trials
Research

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic/pharmacodynamic considerations. / Hilleman, Daniel E.; Nair, C. K.

In: Cardiovascular Reviews and Reports, Vol. 13, No. 11, 1992, p. 15-20+25.

Research output: Contribution to journalReview article

@article{3a950ed66ec940d797eadb231b25482c,
title = "Cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic/pharmacodynamic considerations",
abstract = "Advancing age is associated with important changes in the absorption, distribution, metabolism, and elimination of cardiovascular drugs. In this issue, Drs. Hilleman and Nair discuss cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic and pharmacodynamic considerations. Following this, Dr. Rich reviews three recent articles on the use of angiotensin-converting-enzyme inhibitors in patients at risk for developing congestive heart failure, and another article on the exclusion of elderly subjects and women from clinical trials of pharmacologic interventions in acute myocardial infarction. Also included in this issue are a comprehensive annotated bibliography of the recent literature relevant to cardiovascular disease in the elderly, a report from the Council on Geriatric Cardiology summarizing recent research activities of the Council, and a calendar of upcoming meetings and events.",
author = "Hilleman, {Daniel E.} and Nair, {C. K.}",
year = "1992",
language = "English",
volume = "13",
pages = "15--20+25",
journal = "Cardiovascular Reviews and Reports",
issn = "0197-3118",
publisher = "Le Jacq Communications, Inc.",
number = "11",

}

TY - JOUR

T1 - Cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic/pharmacodynamic considerations

AU - Hilleman, Daniel E.

AU - Nair, C. K.

PY - 1992

Y1 - 1992

N2 - Advancing age is associated with important changes in the absorption, distribution, metabolism, and elimination of cardiovascular drugs. In this issue, Drs. Hilleman and Nair discuss cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic and pharmacodynamic considerations. Following this, Dr. Rich reviews three recent articles on the use of angiotensin-converting-enzyme inhibitors in patients at risk for developing congestive heart failure, and another article on the exclusion of elderly subjects and women from clinical trials of pharmacologic interventions in acute myocardial infarction. Also included in this issue are a comprehensive annotated bibliography of the recent literature relevant to cardiovascular disease in the elderly, a report from the Council on Geriatric Cardiology summarizing recent research activities of the Council, and a calendar of upcoming meetings and events.

AB - Advancing age is associated with important changes in the absorption, distribution, metabolism, and elimination of cardiovascular drugs. In this issue, Drs. Hilleman and Nair discuss cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic and pharmacodynamic considerations. Following this, Dr. Rich reviews three recent articles on the use of angiotensin-converting-enzyme inhibitors in patients at risk for developing congestive heart failure, and another article on the exclusion of elderly subjects and women from clinical trials of pharmacologic interventions in acute myocardial infarction. Also included in this issue are a comprehensive annotated bibliography of the recent literature relevant to cardiovascular disease in the elderly, a report from the Council on Geriatric Cardiology summarizing recent research activities of the Council, and a calendar of upcoming meetings and events.

UR - http://www.scopus.com/inward/record.url?scp=0026446286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026446286&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0026446286

VL - 13

SP - 15-20+25

JO - Cardiovascular Reviews and Reports

JF - Cardiovascular Reviews and Reports

SN - 0197-3118

IS - 11

ER -